News
FDA fast-tracks AskBio’s heart failure gene therapy
A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficac
Digital
Sponsored
Innovation as Strategy: Enabling life sciences of the future
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
R&D
The many trends reshaping clinical trials: An interview with...
Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
Sales & Marketing
Sponsored
How doctors are interacting with content in 10 data trends
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
Oncology
Sponsored
Patient Centricity to Integration: Enhancing Cancer Outcomes
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
R&D
Partner Content
FT US PHARMA AND BIOTECH SUMMIT
2024 is a pivotal year for the US healthcare sector.
R&D
Partner Content
3rd HF Drug Discovery & Development Summit
The Industry’s Only Definitive Forum for Preclinical Heart Failure Drug Development
Category :
barelonalive 2016
/
